Strengthening the Supply of Routinely Recommended Vaccines in the United States: Recommendations from the National Vaccine Advisory Committee

JAMA

Volumn 290, Issue 23, 2003, Pages 3122-3128

  Peter, Georges ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACELLULAR VACCINE; CHICKENPOX VACCINE; DIPHTHERIA TOXOID; MEASLES MUMPS RUBELLA VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; TETANUS TOXOID; VACCINE;

DRUG STORAGE; FOOD AND DRUG ADMINISTRATION; GOVERNMENT; HEALTH PROGRAM; PRIORITY JOURNAL; PROFIT; REVIEW; UNITED STATES; VACCINATION; VACCINE PRODUCTION;

EID: 0347380143     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.290.23.3122     Document Type: Review

References (29)

1. Centers for Disease Control and Prevention. Update on the supply of tetanus and diphtheria toxoids and of diphtheria and tetanus toxoids and acellular pertussis vaccine. MMWR Morb Mortal Wkly Rep. 2001;50:189-190.
2. Centers for Disease Control and Prevention. Shortage of varicella and measles, mumps, and rubella vaccines and interim recommendations from the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2002;51:190-191.
3. Centers for Disease Control and Prevention. Decreased availability of pneumococcal conjugate vaccine. MMWR Morb Mortal Wkly Rep. 2001;50:783-784.
4. Centers for Disease Control and Prevention. Shortage of tetanus and diphtheria toxoids. MMWR Morb Mortal Wkly Rep. 2000;49:1029-1030.
5. Centers for Disease Control and Prevention. Deferral of routine booster doses of tetanus and diphtheria toxoids for adolescents and adults. MMWR Morb Mortal Wkly Rep. 2001;50:418, 427.
6. Centers for Disease Control and Prevention. Update: supply of diphtheria and tetanus toxoids and acellular pertussis vaccine. MMWR Morb Mortal Wkly Rep. 2002;50:1159.
7. Centers for Disease Control and Prevention. Updated recommendations on the use of pneumococcal conjugate vaccine in a setting of vaccine shortage-Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2001;50:1140-1142.
8. Centers for Disease Control and Prevention. Resumption of routine schedule for tetanus and diphtheria toxoids. MMWR Morb Mortal Wkly Rep. 2002;51:529-530.
9. Centers for Disease Control and Prevention. Resumption of routine schedule for diphtheria toxoids and acellular pertussis vaccine and for measles, mumps, and rubella vaccine. MMWR Morb Mortal Wkly Rep. 2002;51:598-599.
10. Centers for Disease Control and Prevention. Resumption of routine use of varicella vaccine. MMWR Morb Mortal Wkly Rep. 2002;51:679.
11. Childhood Vaccines: Ensuring an Adequate Supply Poses Continuing Challenges. Washington, DC: US General Accounting Office; 2002. Publication GAO-02-987. Available at: http://www.gao.gov/new.items/d02987.pdf. Accessed March 26, 2003.
12. Pauley M, Robinson CA, Sepe SJ, Sing M, William MK, eds. Supplying Vaccine: An Economic Analysis of Critical Issues. Washington, DC: IOS Press; 1996.
13. Health Resources and Services Administration. Information about the National Vaccine Injury Compensation Program. Available at: http://www.hrsa.gov/osp/vicp/. Accessed September 24, 2003.
14. Centers for Disease Control and Prevention. Ten great public health achievements-United States, 1900-1999. MMWR Morb Mortal Wkly Rep. 1999;48:241-243.
15. Davis MM, Kemper AR. Valuing childhood vaccines. J Pediatr. In press.
16. Davies P, Chapman S, Leask J. Antivaccination activists on the World Wide Web. Arch Dis Child. 2002;87:22-25.
17. Wolfe RM, Sharp LK, Lipsky MS. Content and design attributes of antivaccination web sites. JAMA. 2002;287:3245-3248.
18. Food and Drug Administration. Information about the Center for Biologics Evaluation and Research. Available at: http://www.fda.gov/cber/index.html. Accessed January 29, 2003.
19. 21 CFR §10-211.
20. Barker LE, Laywoman ET. Changes in vaccination coverage estimates among children aged 19-35 months in the United States, 1996-1999. Am J Rev Med. 2001;20:28-31.
21. Institute of Medicine. Financing Vaccines in the sw Century: Assuring Access and Availability. Washington, DC: National Academy Press; 2003.
22. Food and Drug Administration. Common Technical Document implementation action plan. Available at: http://www.fda.gov/cber/cad/ctdplan.ham. Accessed January 29, 2003.
23. Food and Drug Administration. FDA completes first steps of its broad initiative to improve regulation of pharmaceutical manufacturing. Available at: http: //www.fda.gov/bibs/topics/NEWS/2003/NEW00872 .html. Accessed March 26, 2003.
24. Food and Drug Administration. Prescription drug user fees. Available at: http://www.fda.gov/oc/pdufa/default.ham. Accessed January 29, 2003.
25. Food and Drug Administration. FDA Modernization Act. Available at: http://www.fda.gov/opacom /7modact.html. Accessed January 29, 2003.
26. Centers for Disease Control and Prevention. National Vaccine Program Office welcome center. Available at: http://www.cdc.gov/od/nvpo/. Accessed September 24, 2003.
27. Wilder E. A status report on pediatric vaccine stockpiles. Presented at: National Vaccine Advisory Committee Meeting; October 8-9, 2003; Washington, DC.
28. Centers for Disease Control and Prevention. Current vaccine delays and shortages. Available at: http: //www.cdc.gov/nip/news/shortages/default.ham. Accessed September 24, 2003.
29. Institute of Medicine. Immunization safety review. Available at: http://www.iom.edu/project.asp?id=4705. Accessed September 9, 2003.